FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering - Seite 2

Nachrichtenquelle: Business Wire (engl.)
21.10.2020, 13:30  |  426   |  0   |   

FSD Pharma Registered (B) Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de

Diesen Artikel teilen
Seite 2 von 2
Wertpapier


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering - Seite 2 FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company …

Nachrichten des Autors

Titel
IBM Board Approves Regular Quarterly Cash Dividend
Walgreens Boots Alliance Appoints Rosalind Brewer as Chief Executive Officer, and Stefano Pessina ...
FSD Provides Corporate Update
AT&T Reports Fourth-Quarter and Full-Year Results
TransferWise and Visa Announce Global Partnership Following Successful Collaboration on Cloud ...
Tradeweb Appoints James Sun as Head of Asia
Veolia Will Oppose Any Sale of Suez Strategic Assets Opposing Its Industrial Plan
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against ...
2021 ISG Events to Focus on Post-Pandemic Resurgence
Starbucks Reports Q1 Fiscal 2021 Results
Titel
AMC Raises $917 Million of Fresh Investment Capital Since Mid-December of 2020
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) for Adult Patients with Active Lupus ...
Europcar Mobility Group in a Position to Finalize Its Financial Restructuring Plan and Accelerate ...
Lauren Friedman Stat Joins Palantir Board of Directors
Rare Element Resources Named U.S. Department of Energy Funding Recipient for Rare Earth Separation ...
Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan ...
EVgo, an LS Power Company, and Leader in U.S. Electric Vehicle Fast Charging, to Publicly List ...
Mapbox launches 3D Maps with 135 million sq km of global, high-resolution imagery from Maxar
Cresco Labs Announces Closing of Offering of Subordinate Voting Shares
TILRAY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Tilray, Inc. - TLRY
Titel
BevCanna's Pure Therapy Reports Record Monthly Revenue
Accenture Acquires Real Protect, Brazil-Based Information Security Company
PPG to Acquire Global Coatings Manufacturer Wörwag
AMC Raises $917 Million of Fresh Investment Capital Since Mid-December of 2020
Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
FDA Approves Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) for Adult Patients with Active Lupus ...
Argo Blockchain Commences Trading on the OTCQB Venture Market in the United States
#1 U.S Cannabis Beverage Company Keef Brands Takes Equity Position in BevCanna
BevCanna Completes $5M Capital Injection, Including a Fully-Subscribed $3.5M Above Market Offering ...
Carbios Significantly Strengthened Its International Patent Portfolio
Titel
WEX Merchant Partners Offer Fuel Discounts to Truckers
Dolores J. Ennico Nominated to Join RBC Bearings Board of Directors
Cypress Unveils IoT-AdvantEdge Solutions Providing Developers a Trusted Design Path to IoT Edge ...
Halo Labs President Katie Field to Present at the 2020 Virtual Benzinga Cannabis Capital Conference
Halo Announces Results of Annual General Meeting
Halo Provides Operational Update
Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic
Halo Enters Into Second Amended and Restated Convertible Promissory Note For Aggregate Principal ...
Wells Fargo Bank Decreases Prime Rate to 4.25 Percent
Halo Labs Provides Oregon Business Update

Nachrichten zu den Werten

ZeitTitel
01:30 Uhr
FSD Provides Corporate Update
22.01.21
FSD Pharma Sets Date for Annual Meeting
01.01.21
Cannabis Aktien: Enttäuschend – ABER mit Potenzial! Canopy, Aphria, Cronos und Aurora Cannabis

COMMUNITY

ZeitTitel
08:06 Uhr
28
FSD Pharma Announces Phase 2 Clinical Trial IND Filing With The FDA to Treat Patients With COVID-19
24.08.20
157
Willkommen bei FSD nach dem RS
20.02.20
5.569
FSD Pharma und Scicann Therapeutics starten klinisches Forschungsprogramm in Israel